All Articles

In the chaotic, high-stakes world of pharma tradeshows, success is no longer about free pens. It's about strategy, psychology, and navigating regulations.

A nod from Forrester is more than a headline. It reveals a quiet revolution where specialized software empowers logistics operators and redefines enterprise value.

As Mount Pleasant Group marks its 200th anniversary, it's deploying goats and bees to manage historic grounds, transforming spaces of remembrance into vibrant ecosystems.

Defiance just launched an ETF to short the newly public SpaceX. We dive into the high-stakes gamble on a trillion-dollar titan and the perilous tools of modern trading.

In a strategic move reshaping the DFW digital marketing landscape, Fast Hippo Media has acquired Plano Website Design, uniting local expertise with advanced AI.

When disaster strikes, 40% of small firms never reopen. A deep dive into business interruption insurance reveals what's covered, what's not, and why.

Developer Robert Morgan pitches a people-first revitalization plan, but a complex history and the reality of urban displacement reveal a deeper story.

CrowdStrike's new Continuous Identity platform isn't just a product; it's a foundational shift for securing the coming wave of autonomous AI agents.

A $79M project is converting a vacant Québec City office tower into 222 affordable homes, a bold new model for tackling Canada's housing and office crises.

A new report reveals less than half of Ontario's long-term care homes got proactive inspections, exposing a deep disconnect between policy and resident safety.

Nordicus Partners reveals promising data for gum disease and oral lesions, betting its future on a unique Nordic acquisition strategy and a Nasdaq uplisting.

AI is no longer just advising on financial transactions—it's executing them. A new initiative by industry leaders aims to write the rules before it's too late.

A strategic integration between Onera Health and ResMed's Somnoware is set to dismantle the biggest barriers in sleep medicine by moving gold-standard tests home.

A new "barcode scam" is fueling a surge in losses for utility customers. PG&E reports a grim trend, but this is a nationwide problem. Here's the playbook.

A new M&A hire signals CyberAI's plan to buy its way to a $100M revenue goal and an IPO, betting its future on market consolidation and AI innovation.

A new clinical trial, backed by the Michael J. Fox Foundation, tests a radical idea: an oral drug derived from carbon monoxide to fight Parkinson's.

Targeting advisor frustration, Wallace Finance launches a unified AI platform for wealth managers, aiming to cut costs and democratize advanced investing.

With a new critical illness feature, AuguStar Life is challenging the insurance industry's opaque benefit models with a clear, predictable lien system.

Startup Crumb just won a major tech award for its pet safety platform. Its secret? An AI that scans your dog's nose print, creating an unforgeable ID.

Beyond eco-friendly plastics, Envalior's latest report reveals a strategy built on validated data, making materials a critical node in the sustainability network.